MedPath

Mannitol

These highlights do not include all the information needed to use MANNITOL INJECTION safely and effectively. See full prescribing information for MANNITOL INJECTION. MANNITOL injection, for intravenous use Initial U.S. Approval: 1964

Approved
Approval ID

8ad3145e-00e7-4412-b9a5-06f00f264f30

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 30, 2020

Manufacturers
FDA

Hospira, Inc.

DUNS: 141588017

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

MANNITOL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0409-4031
Application NumberNDA016269
Product Classification
M
Marketing Category
C73594
G
Generic Name
MANNITOL
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMarch 30, 2020
FDA Product Classification

INGREDIENTS (4)

MANNITOLActive
Quantity: 12.5 g in 50 mL
Code: 3OWL53L36A
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM BICARBONATEInactive
Code: 8MDF5V39QO
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.